DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Adverum Biotechnologies Q4 EPS $(0.29), Inline

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(0.29) per share which met the analyst consensus estimate. This is a 16 percent decrease over losses of $(0.25) per share from the same period last

Benzinga · 03/12/2020 20:06

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(0.29) per share which met the analyst consensus estimate. This is a 16 percent decrease over losses of $(0.25) per share from the same period last year.